Oaktree Acquisition Corp. III Life Sciences (OACC) Change in Account Payables (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Change in Account Payables of $75000.0 for Q1 2026, down 84.4% on a YoY basis from $480833.0 in Q1 2025, and little changed quarter-over-quarter from $75000.0 in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Change in Account Payables (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Change in Account Payables for 2 years, with the latest figure at $75000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables fell 84.4% year-over-year to $75000.0; the trailing twelve-month figure through Mar 2026 stood at $380024.0 (changed N/A YoY), and the FY2025 full-year result was $785857.0, changed N/A from the prior year.
  • Change in Account Payables for Q1 2026 stood at $75000.0, roughly flat from $75000.0 in the prior quarter.
  • The five-year high for Change in Account Payables was $480833.0 in Q1 2025, with the low at $75000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - -
2 Berto Acquisition 312.46 Mn 312.46 Mn - -1,876.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - -
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - -
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -
6 WEN Acquisition 309.15 Mn 309.15 Mn - -
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - 4,745.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - -
9 BTC Development 262.16 Mn 262.16 Mn - -
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - 75,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 75,000.00
Mar 31, 2026 75,000.00
Dec 31, 2025 75,000.00
Dec 31, 2025 75,000.00
Sep 30, 2025 75,000.00
Sep 30, 2025 75,000.00
Jun 30, 2025 155,024.00
Jun 30, 2025 155,024.00
Mar 31, 2025 480,833.00
Mar 31, 2025 480,833.00